Fairvalue-Calculator Fairvalue-Calculator
EN DE

NexPoint Residential Trust, Inc (NXRT) Fair Value & Analysis

Real Estate · US · Market cap $1.4B

Price$27.73
Fair Value$21.92
Upside-21.0%
Quality95/100
Evidence: High Range $4.38 – $42.54

Analysis

NexPoint Residential Trust, Inc (NXRT) currently trades at $27.73, while our model-based Fair Value estimate is $21.92 — implying the stock looks roughly 21.0% overvalued today. We read business quality at 95/100 (high quality), in the Real Estate sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

NexPoint Residential Trust, Inc. is a publicly traded real estate investment trust. With its common stock listed on the New York Stock Exchange and primarily focused on acquiring, owning and operating well-located middle-income multifamily properties with value-add potential in large cities and suburban submarkets of large cities, primarily in the Southeastern and Southwestern United States. NXRT is externally advised by NexPoint Real Estate Advisors, L.P., an affiliate of NexPoint Advisors, L.P., an SEC-registered investment advisor, which has extensive real estate experience. NexPoint Residential Trust, Inc. was established on September 19, 2014 and is based in Dallas, United States.

Open the full interactive analysis →

Similar stocks

AvalonBay Communities, Inc (A1VB34) -88% EQR (EQR) -13% E1QR34 (E1QR34) -81% Essex Property Trust, Inc (ESS) -36% Invitation Homes (INVH) -19% Mid-America Apartment Communities, Inc (MAA) -51%

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.